KGET
CaliPharms, Inc.
Set alert
0.00 USD 0.00 0.00%
0.000001 Day range 0.000001
0.000001 52-week range 0.00004
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.000001
- Prev close
- 0.00004
- Mkt cap
- 160.52K
- Vol
- 680
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.000001
- High
- 0.000001
Financial health
Altman Z-Score
-3608.32 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.0×
FY 2012 5y median -1.0× FY 2017
P/S 89.8×
FY 2012 5y median 0.0× FY 2017
P/B -0.3×
FY 2012 5y median -0.1× FY 2017
P/FCF -6.6×
FY 2012 5y median -12.1× FY 2017
EV/EBITDA -1.1×
FY 2012 5y median -4.1× FY 2017
EV/Sales 119×
FY 2012 5y median 0.0× FY 2017
FCF Yield -15.0%
FY 2012 5y median -0.8% FY 2017
Profitability
Gross Margin 100.0%
FY 2012 5y median 0.0% FY 2017
Operating Margin -11222.7%
FY 2012 5y median 0.0% FY 2017
Net Margin -11861.4%
FY 2012 5y median 0.0% FY 2017
ROE 35.9%
FY 2012 5y median 9.7% FY 2017
ROIC 37.4%
FY 2012 5y median 3.7% FY 2017
ROA -7495.4%
FY 2012 5y median -7495.4% FY 2017
Growth (YoY)
Revenue 0.0%
FY 2012 FY 2017
Operating Income -276.3%
FY 2012 FY 2017
EPS (diluted) 0.0%
FY 2012 FY 2017
Free Cash Flow -1445.3%
FY 2012 FY 2017
Financial Health
Current Ratio 0.0×
FY 2012 5y median 0.0× FY 2017
Quick Ratio 0.0×
FY 2012 5y median 0.0× FY 2017
Debt / Equity -0.1×
FY 2012 5y median -0.1× FY 2017
Net Debt / EBITDA -0.3×
FY 2012 5y median -0.3× FY 2017
Interest Coverage -17.6×
FY 2012 5y median -1.3× FY 2017
Dividends
Dividend Yield 0.0%
FY 2012 5y median 0.0% FY 2017
Payout Ratio 0.0%
FY 2012 5y median 0.0% FY 2017
Annual · latest fiscal year ends 2017-12-31